Literature DB >> 11851900

Hypervariable region 1 quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels.

T Asselah1, M Martinot, D Cazals-Hatem, N Boyer, A Auperin, V Le Breton, S Erlinger, C Degott, D Valla, P Marcellin.   

Abstract

The role of hepatitis C virus (HCV) heterogeneity in the severity of chronic hepatitis C infection remains unclear. Our aim was to study the hypervariable region 1 (HVR1) heterogeneity in patients with chronic hepatitis C infected with genotype 1b or 3 and with normal or abnormal alanine aminotransferase (ALT). HVR1 quasispecies were assessed by single strand conformational polymorphism (SSCP) in 67 patients with chronic hepatitis C, including 35 with persistently normal ALT and 32 with abnormal ALT. Sixty-two patients underwent a liver biopsy. Among the 67 patients, 40 were infected with genotype 1b and 27 with genotype 3. In univariate analysis, low heterogeneity (<or= 3 bands at SSCP) was significantly associated with normal ALT (P < 0.001), milder histological lesions (activity, P=0.02; fibrosis, P=0.04), and at the limit of significance for genotype 1b (P=0.07). In multivariate analysis, low heterogeneity was significantly and independently associated with normal ALT (P=0.09) and genotype 1b (P=0.03). In patients with chronic hepatitis C, a low viral heterogeneity is significantly and independently associated with normal ALT and genotype 1b. These results are consistent with the view that patients with normal ALT have a different immune response against HCV resulting in a low HCV heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11851900     DOI: 10.1046/j.1365-2893.2002.00327.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  7 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 2.  Steatosis in chronic hepatitis C: why does it really matter?

Authors:  T Asselah; L Rubbia-Brandt; P Marcellin; F Negro
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

3.  Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome.

Authors:  Gianguglielmo Zehender; Chiara De Maddalena; Flavia Bernini; Erika Ebranati; Giuseppe Monti; Piero Pioltelli; Massimo Galli
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3.

Authors:  Samir R Shah; Keyur Patel; Patrick Marcellin; Graham R Foster; Michael Manns; Shyam Kottilil; Letha Healey; Erik Pulkstenis; G Mani Subramanian; John G McHutchison; Mark S Sulkowski; Stefan Zeuzem; David R Nelson
Journal:  Clin Gastroenterol Hepatol       Date:  2011-05-13       Impact factor: 11.382

5.  Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C.

Authors:  T Asselah; N Boyer; M-C Guimont; D Cazals-Hatem; F Tubach; K Nahon; H Daïkha; D Vidaud; M Martinot; M Vidaud; C Degott; D Valla; P Marcellin
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

Review 6.  Hepatic steatosis: a benign disease or a silent killer.

Authors:  Abdel-Rahman El-Zayadi
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

Review 7.  Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.

Authors:  Tarik Asselah; Emilie Estrabaud; Ivan Bieche; Martine Lapalus; Simon De Muynck; Michel Vidaud; David Saadoun; Vassili Soumelis; Patrick Marcellin
Journal:  Liver Int       Date:  2010-10       Impact factor: 5.828

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.